| Aug 6 |
ADC Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update
|
| Aug 1 |
Vertex Pharmaceuticals (VRTX) Reports Q2 Loss, Misses Revenue Estimates
|
| Jul 30 |
ADC Therapeutics to Host Second Quarter 2024 Financial Results Conference Call on August 6, 2024
|
| Jul 11 |
7 Growth Stocks to Buy for Under $5 for Massive Gains
|
| Jul 8 |
Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development
|
| Jun 29 |
ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value Estimate
|
| Jun 27 |
ADC Therapeutics to join Russell 2000 index
|
| Jun 27 |
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
|
| Jun 13 |
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
|
| Jun 6 |
Limiting Concerns On ADC Therapeutics' Prospects
|
